TP53 germline testing and hereditary cancer: how somatic events and clinical criteria affect variant detection rate.
Rofes P, Castillo-Manzano C, Menéndez M, Teulé Á, Iglesias S, Munté E, Ramos-Muntada M, Gómez C, Tornero E, Darder E, Montes E, Valle L, Capellá G, Pineda M, Brunet J, Feliubadaló L, Del Valle J, Lázaro C.
Rofes P, et al. Among authors: gomez c.
Genome Med. 2025 Jan 14;17(1):3. doi: 10.1186/s13073-025-01429-5.
Genome Med. 2025.
PMID: 39810221
Free PMC article.